1. Home
  2. PBI vs VIR Comparison

PBI vs VIR Comparison

Compare PBI & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pitney Bowes Inc.

PBI

Pitney Bowes Inc.

HOLD

Current Price

$10.87

Market Cap

1.6B

Sector

Miscellaneous

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$8.40

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBI
VIR
Founded
1920
2016
Country
United States
United States
Employees
6600
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PBI
VIR
Price
$10.87
$8.40
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$11.67
$19.63
AVG Volume (30 Days)
2.7M
3.5M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
3.29%
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,049.62
P/E Ratio
$13.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.40
$4.16
52 Week High
$13.11
$10.91

Technical Indicators

Market Signals
Indicator
PBI
VIR
Relative Strength Index (RSI) 57.56 45.05
Support Level $9.78 $5.14
Resistance Level $11.72 $10.29
Average True Range (ATR) 0.34 0.47
MACD 0.07 -0.18
Stochastic Oscillator 85.97 3.20

Price Performance

Historical Comparison
PBI
VIR

About PBI Pitney Bowes Inc.

Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal work sharing discounts. It derives maximum revenue from SendTech Solutions.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: